Search
for
Sort by
Research 31–60 of 190
- Hormone therapy in acne
- Provision of Patient‐Centered Transgender Care
- Interaction of spironolactone with rat skin androgen receptor
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- The Hirsute Woman: Challenges in Evaluation and Management
- Contraceptive use in acne
- Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy
- Spironolactone‐induced hepatitis
- Spironolactone in the Treatment of Hirsutism
- Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris
- Menopausal Acne – Challenges And Solutions
- The use of hormonal agents in the treatment of acne
- Association of Spironolactone Use With Risk of Cancer
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- The Acute Anticonvulsant Effects of Deoxycorticosterone in Developing Rats: Role of Metabolites and Mineralocorticoid‐receptor Responses
- Medical treatment regimens of hirsutism
- Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder
- Other Antiandrogens
- Spironolactone use does not increase the risk of female breast cancer recurrence: A retrospective analysis
- Polycystic ovary syndrome
- Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- Polycystic Ovary Syndrome
- Hirsutism
- Uso de la espironolactona en dermatología: acné, hidradenitis supurativa, alopecia femenina e hirsutismo
- Hirsutism causes and treatments.
- Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
- A novel actor in skin biology: the mineralocorticoid receptor